Use of early nasal continuous positive airway pressure in preterm neonates with hyaline membrane disease (neonatal respiratory distress syndrome)
DOI:
https://doi.org/10.18203/2349-3291.ijcp20210652Keywords:
Respiratory distress syndrome, Preterm neonates, Hyaline membrane disease, Nasal CPAPAbstract
Background: In developing countries like ours, there is high burden of prematurity and sub-optimal use of antenatal steroid administration resulting infrequent hyaline membrane disease (HMD).
Methods: A total 50 cases of clinically diagnosed HMD with gestational age between 28-34 weeks admitted to neonatal intensive care unit (ICU). 50 babies were treated with early nasal continuous positive airway pressure (CPAP) (within 6 hours of onset of respiratory distress).
Results: Incidence of prematurity was 12.42%. Incidence of HMD observed between gestational ages of 28-34 weeks is 3.2%. Out of total 50 babies who were managed with early nasal CPAP, it proved effective in 40 babies (80%), remaining 10 babies (20%) had to be intubated and required ventilation. Out of 10 babies who required ventilation 90% of the babies were less than 32 weeks gestation age; remaining 10% were between 33-34 weeks. Analysis of these results showed that outcome is better with increased gestational age (p<0.005). Out of 10 babies who failed 80% were <1500 g and remaining 20% above 1500 g. We found significant improvement (p<0.005) in SA score after application of nasal CPAP. Babies on CPAP had significant improvement in oxygenation (p<0.05). A success rate of 93.1% observed in moderate grade HMD (p<0.005). Out of 10 babies who failed on nasal CPAP, 80% of them had severe grade HMD and 20% showed moderate HMD. A success rate of 92.86% was found in babies of mothers who had received antenatal steroids and 63.63% of babies whose mothers had not received antenatal steroids improved with early nasal CPAP (p<0.05).
Conclusions: Nasal CPAP is found to be effective in babies of mothers who had received antenatal steroids. Nasal CPAP is safe, inexpensive and effective means of respiratory support in HMD. Use of early nasal CPAP which is simple, non-invasive, has low capital outlay and does not require expertise, is the option for us where most places cannot provide invasive ventilation.
References
Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Children. 1959;97(5):517-23.
Whitsett JA, Pryhuber GS, Rice WR, Warner BB, Wert SE. Acute respiratory disorders. In: Avery GB, Fletcher MA, MacDonald MG (eds), Neonatology: Pathophysiology and Management of the Newborn, 4 ed. Philadelphia: J.B. Lippincott Company. 1994:429-52.
Saunders RA, Milner AD, Hopkins IE. The effects of CPAP on lung mechanics and lung volumes in the neonates. Biol Neonate. 1976;29:178-84.
Harris TR, Wood BR. Physiologic Principles. In: Goldsmith JP, Karotkin EH eds. Assisted Ventilation, 3rd edn. Philadelphia; WB Saunders. 1996;21-68.
Michna J, Jobe AH, Ikegami M. Positive end expiratory pressure preserves surfactant function in preterm lambs. Am J Resp Crit Care Med. 1999;60:634-9.
Lawson EE, Birdwell RL, Huang PS. Augmentation of pulmonary surfactant secretion by lung expansion at birth. Pediatr Res. 1979;13:611-4.
Locker R, Greenspan JS, Shaffer TS. Effect of nasal CPAP on thoraco-abdominal motion in neonates with respiratory insufficiency. Pediatr Res. 1994;11:259-64.
De Klerk AM, De Klerk RK. Use of continuous positive airway pressure in pretern infants: Comments and experience from New Zealand. Pediatrics 2001;108:761-2.
Diblasi RM. Nasal continuous positive airway pressure (CPAP) for the respiratory care of the newborn infant. Respiratory care. 2009;54(9):1209-35.
Sekar K. The role of continuous positive airway pressure therapy in the management of respiratory distress in extremely premature infants. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2006;11(3):145-52.
Sekar KC, Corff KE. To tube or not to tube babies with respiratory distress syndrome. J Pathol. 2009;29:S68-72.
Upadhyay A, Deorari AK. Continuous positive airway pressure - a gentler approach to ventilation. Indian pediatrics. 2004;41(5):459-69.
Kamper J, Ringsted C. Early treatment of idiopathic respiratory distress syndrome using binasal continuous positive airway pressure. Acta Pediatr Scand. 1990;79:581-6
Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. European journal of pediatrics. 1997;156(5):384-8.
Aly H, Milner JD, Patel K et al. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004;9(114):697-702
Schmid ER, Dangel PH, Duc GV. The use of nasal CPAP in newborns with RDS. Eur J Intensive Care Med. 1976; 2(3): 125-30.
Sandri F, Ancora G, Lanzoni A. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestations: multicenter randomized controlled clinical trial. Arch Dis Child Fetal Neonatal Ed. 2004;89(5):F394-8.
